Experiment: 7KNV

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
14	2D 1H-15N HSQC	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Bruker AVANCE III 600
1	3D HNCACB	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Bruker AVANCE III 600
2	3D CBCA(CO)NH	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Bruker AVANCE III 600
3	3D HNCA	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Bruker AVANCE III 600
4	3D HN(CO)CA	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Bruker AVANCE III 600
5	3D HN(CA)CO	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
6	3D HNCO	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
7	3D HBHA(CO)NH	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
8	3D HCCH-TOCSY	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
9	3D HCCH-TOCSY	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 800
10	3D HCCH-COSY	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 800
11	3D NOESY 1H-15N HSQC	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
12	3D NOESY 1H-13C HSQC aliphatic	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 600
13	2D 1H-13C HSQC aliphatic	0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O	90% H2O/10% D2O	380 mM	7.0	1 atm	293	Varian VNMR 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Varian	VNMR	600
3	Varian	VNMR	800

NMR Refinement
Method	Details	Software
simulated annealing		PONDEROSA-C/S
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	400
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	peak picking	NMRFAM-SPARKY		Lee, Tonelli, Markley
4	chemical shift assignment	I-PINE		Lee, Bahrami, Dashti, Eghbalnia, Tonelli, Westler and Markley
5	structure calculation	PONDEROSA-C/S		Lee, Petit, Cornilescu, Stark and Markley
6	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.